fda semaglutide warning september 2025 warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain FDA: Novo Nordisk's Ozempic and

GLP1 agonists are injectible medications that mimic a hormone called glucagon-like peptide-1, which prompts the pancreas to make more insulin

None of the Author, BMW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information

But beneath the surface of glossy marketing and fitness fantasies lies a far more sobering truth: many of these substances operate in a medical grey zone, with unknown long-term risks, questionable manufacturing standards, and in some cases, life-threatening side-effects

Weight loss injections decrease your appetite and cravings for certain foods to help reduce your calorie intake